BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 8854398)

  • 1. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current viewpoints in the anti-D prevention of rhesus alloimmunization in the pregnant woman and of hemolytic disease of the newborn infant (a review of the literature)].
    Spasova K; Vŭlcheva B
    Akush Ginekol (Sofiia); 1986; 25(3):84-90. PubMed ID: 3019168
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 4. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood group frequencies and ABO and RhD incompatibilities in La Paz, Baja California Sur, Mexico].
    del Peón-Hidalgo L; Pacheco-Cano MG; Zavala-Ruiz M; Madueño-López A; García-González A
    Salud Publica Mex; 2002; 44(5):406-12. PubMed ID: 12389483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Rh hemolytic disease of the newborn.
    Jennings ER; Dibbern HH; Hodell FH; Monroe CH; Peckham NH; Sullivan JF; Pollack W
    Calif Med; 1969 Feb; 110(2):130-3. PubMed ID: 4181977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of the number of females at risk of isoimmunization to the Rho (D) antigen in a sample of the population attended at the Instituto Mexicano del Seguro Social.
    Zavala C; Velázquez-Ferrari MA; Navarrete C; Rosales-Corona J; Lisker R
    Arch Invest Med (Mex); 1983; 14(2):199-206. PubMed ID: 6416200
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of Rh immunization by anti-D globulin injection after birth and abortion].
    Vardy J; Halbrecht I
    Harefuah; 1972 Aug; 83(3):115-20. PubMed ID: 4118291
    [No Abstract]   [Full Text] [Related]  

  • 10. [New recommendations for the completion of rhesus-immunization prophylaxis with anti-D].
    Maas DH; Schneider J
    Immun Infekt; 1982 Nov; 10(6):244-9. PubMed ID: 6307863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of Rh haemolytic disease.
    Clarke CA
    Nurs Mirror Midwives J; 1974 Oct; 139(17):57-9. PubMed ID: 4139694
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical evaluation of Rho(D) immune globulin (human) in Canada.
    Bryant EC; Hart GD; Cairns D; Gamarra JA; de Veber LL; Holland CG; Hutchison JL
    Can Med Assoc J; 1969 Dec; 101(12):82-3. PubMed ID: 4188450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rh immune globulin after genetic amniocentesis: impact on pregnancy outcome.
    Crane JP; Rohland B; Larson D
    Am J Med Genet; 1984 Dec; 19(4):763-8. PubMed ID: 6097129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloimmunization in pregnancy during the years 1992-2005 in the central west region of Sweden.
    Gottvall T; Filbey D
    Acta Obstet Gynecol Scand; 2008; 87(8):843-8. PubMed ID: 18704776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of anti-D allo-immunization during pregnancy].
    Branger B; Winer N
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages of preventing Rh isoimmunization].
    Mikulandra F; Merlak I; Perisa M; Kapitanović Z; Barbetti V; Kimer M; Glavadanović N
    Jugosl Ginekol Perinatol; 1985; 25(1-2):29-34. PubMed ID: 3003466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E; Cavelier B; Bonneau JC; Rouger P
    Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-D prophylaxis after abortions and interruptions].
    Maas DH
    Fortschr Med; 1979 Jan; 97(4):148-52. PubMed ID: 217809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Foetal-maternal alloimmunizations in the South-East area of the Venice province].
    Gessoni G; Valverde S; Giacomini A; Antico F; Salvadego M; Arreghini N; De Fusco G; Fezzi M; Marchiori G; Manoni F
    Minerva Ginecol; 2002 Aug; 54(4):333-8. PubMed ID: 12114866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.